Infectious agents as triggers of reactive arthritis

American Journal of the Medical Sciences

Volumn 316, Issue 4, 1998, Pages 264-270

  Wuorela, Maarit ^a   Granfors, Kaisa ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Chlamydia; Pathogenesis; Reactive arthritis; Salmonella; Yersinia

Indexed keywords

BACTERIAL ANTIGEN; HLA B27 ANTIGEN;

BACTERIAL INFECTION; CHLAMYDIA; CONFERENCE PAPER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; INTESTINE MUCOSA; PATHOGENESIS; REACTIVE ARTHRITIS; SALMONELLA; SYNOVIAL FLUID LEVEL; YERSINIA;

EID: 0031690850     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199810000-00007     Document Type: Conference Paper

References (98)

1. Granfors K. Do bacterial antigens cause reactive arthritis? Rheum Dis Clin North Am. 1992;18:37-48.
2. Sieper J, Kingsley G, Märker-Hermann E. Aetiological agents and immune mechanisms in enterogenic reactive arthritis. Baillìere's Clin Rheumatol. 1996;10:105-21.
3. Falkow S, Isberg RR, Portnoy DA. The interaction of bacteria with mammalian cells. Annu Rev Cell Biol. 1992;8:333-63.
4. Kellner H, Granfors K. Reactive arthritis: mechanisms and drug therapy. Clin Immunother. 1995;4:338-45.
5. Cornelis GR. Yersinia pathogenicity factors. In: Dangl JL, ed. Current Topics in Microbiology and Immunology. Bacterial Pathogenesis of Plants and Animals: Molecular and Cellular Mechanisms. Berlin, Heidelberg: Springer-Verlag; 1994.
6. Isberg RR, Leong JM. Multiple b1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell. 1990;60:861-71.
7. Beuscher HU, Rödel F, Forsberg Å, Röllinghoff M. Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression. Infect Immun. 1995;63:1270-7.
8. Nakajima R, Motin VL, Brubaker RR. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun. 1995;63:3021-9.
9. Skurnik M, Toivanen P. Yersinia enterocolitica lipopolysaccharide: genetics and virulence. Trends Microbiol. 1993; 1:148-52.
10. Rathman M, Barker LP, Falkow S. The unique trafficking pattern of Salmonella typhimurium-containing phagosomes in murine macrophages is independent of the mechanism of bacterial entry. Infect Immun. 1997;65:1475-85.
11. Jones BD, Falkow S. Salmonellosis: host immune responses and bacterial virulence determinants. Annu Rev Immunol. 1996;14:533-61.
12. Granfors K, Viljanen M, Tiilikainen A, Toivanen A. Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis. 1980;141:424-9.
13. Mäki-Ikola O, Leirisalo-Repo M, Kantele A, Toivanen P, Granfors K. Salmonella-specific antibodies in reactive arthritis. J Infect Dis. 1991;164:1141-8.
14. van Bohemen CG, Nabbe AJ, Landheer JE, Grumet FC, Mazurkiewicz ES, Dinant HJ, et al. HLA-B27M1M2 and high immune responsiveness to Shigella flexneri in post-dysenteric arthritis. Immunol Lett. 1986;13:71-4.
15. Hoogkamp-Korstanje JAA, de Koning J, Heesemann J. Persistence of Yersinia enterocolitica in man. Infect Immun. 1988;16:81-5.
16. van der Heijden I, Res P, Wilbrink B, Leow A, Breedfelt F, Heesemann J, Tak P. Yersinia enterocolitica: a cause of chronic polyarthritis. Arthritis Rheum. 1996;39:5186.
17. 16a. Granfors K, Merilahti-Palo R, Luukkainen R, Möttönen T, Lahesmaa R, Probst P, et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum. 1998;41:855-62.
18. Taylor-Robinson D, Gilroy CB, Thomas BJ, Keat ACS. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet. 1992;340:81-2.
19. Bas S, Griffais R, Kvien TK, Glennås A, Melby K, Vischer TL. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum. 1995;38:1005-13.
20. Hammer M, Nettelnbreker E, Hopf S, Schmitz E, Pörschke K, Zeidler H. Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis. Clin Exp Rheumatol. 1992;10:63-6.
21. Branigan PJ, Gérard HC, Hudson AP, Schumacher HR Jr. Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction. Arthritis Rheum. 1996; 39:1740-6.
22. Nanagara R, Li F, Beutler A, Hudson A, Schumacher HR Jr. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes: suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum. 1995;38:1410-7.
23. Viitanen A-M, Arstila TP, Lahesmaa R, Granfors K, Skurnik M, Toivanen P. Application of polymerase chain reaction and immunofluorescence for bacterial detection in Yersinia-triggered reactive arthritis. Arthritis Rheum. 1991;34:89-96.
24. Nikkari S, Merilahti-Palo R, Saario R, Söderström K-O, Granfors K, Skurnik M, Toivanen P. Yersinia-triggered reactive arthritis: use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum. 1992; 35:682-7.
25. Nikkari S, Möttönen T, Saario R, Yli-Kerttula U, Leirisalo-Repo M, Laitio P, Toivanen P. Demonstration of Salmonella DNA in the synovial fluid in reactive arthritis. Arthritis Rheum. 1996;39:S185.
26. García CO, Paira S, Burgos R, Molina J, Molina JF, Calvo C, et al. Detection of Salmonella DNA synovial membrane and synovial fluid from Latin American patients with reactive arthritis using the polymerase chain reaction. Arthritis Rheum. 1996;39:S185.
27. Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomäki O, Pekkola-Heino K, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989;320:216-21.
28. Granfors K, Jalkanen S, Lindberg AA, Mäki-Ikola O, von Essen R, Lahesmaa-Rantala R, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990;335:685-88.
29. Granfors K, Jalkanen S, Toivanen P, Koski J, Lindberg AA. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol. 1992;19:500.
30. Keat A, Thomas B, Dixey J, Osborn M, Sonnex C, Taylor-Robinson D, et al. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet. 1987;1:72-4.
31. Schumacher HR Jr, Magge S, Cherian PV, Sleckman J, Rothfuss S, Clayburne G, Sieck M. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome: immunocytochemical identification of chlamydial antigen in patients with early disease. Arthritis Rheum. 1988;31:937-46.
32. Hammer M, Zeidler H, Klimsa S, Heesemann J. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis Rheum. 1990;33:1795-800.
33. Ledur A, Fitting C, David B, Hamberger C, Cavaillon J-M. Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. J Immunol Methods. 1995;186:171-9.
34. Villiger PM, Terkeltaub R, Lotz M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage: induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest. 1992;90:488-96.
35. Lotz M, Terkeltaub R, Villiger PM. Cartilage and joint inflammation: regulation of IL-8 expression by human articular chondrocytes. J Immunol. 1992;148:466-73.
36. Katona IM, Ohura K, Allen JB, Wahl LM, Chenoweth DE, Wahl SM. Modulation of monocyte chemotactic function in inflammatory lesions: role of inflammatory mediators. J Immunol. 1991;146:708-14.
37. Jasin HE. Bacterial lipopolysaccharides induce in vitro degradation of cartilage matrix through chondrocyte activation. J Clin Invest. 1983;72:2014-9.
38. Kitlick PD, Engelman D. Effect of the microbial constituents, LPS and BGC, on the glycosaminoglycans of chondrocyte cultures. Exp Pathol. 1991;42:145-50.
39. Otterness IG, Bliven ML, Milici AJ, Poole AR. Comparison of mobility changes with histological and biochemical changes during lipopolysaccharide-induced arthritis in the hamster. Am J Pathol. 1994;144:1098-108.
40. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol. 1991;147:3915-20.
41. Sakurai H, Kohsaka H, Liu M-F, Higashiyama H, Hirata Y, Kanno K, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest. 1995;96:2357-63.
42. Oeth P, Mackman N. Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood. 1995;86:4144-52.
43. Wuorela M, Jalkanen S, Toivanen P, Granfors K. Yersinia lipopolysaccharide is modified by human monocytes. Infect Immun. 1993;61:5261-70.
44. Lahesmaa-Rantala R, Granfors K, Isomäki H, Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with Yersinia triggered reactive arthritis. Ann Rheum Dis. 1987;46:510-4.
45. Johnston MG, Hay JB, Movat HZ. Kinetics of prostaglandin production in various inflammatory lesions, measured in draining lymph. Am J Pathol. 1979;95:225-38.
46. Randolph GJ, Furie MB. Mononuclear phagocytes egress from an in vitro model of the vascular wall by migrating across endothelium in the basal to apical direction: role of intercellular adhesion molecule 1 and the CD11/CD18 integrins. J Exp Med. 1996;183:451-62.
47. Schumacher HR Jr. How micro-organisms are handled to localize to joints and within joints. Scand J Rheumatol. 1995;24:199-202.
48. Salmi M, Jalkanen S. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol. 1997;64:139-218.
49. Salmi M, Granfors K, Leirisalo-Repo M, Hämäläinen M, MacDermott R, Leino R, et al. Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc Natl Acad Sci U S A. 1992; 89:11436-40.
50. Kirveskari J, Jalkanen S, Mäki-Ikola O, Granfors K. Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection. Arthritis Rheum. 1998;41:1054-63.
51. Salmi M, Rajala P, Jalkanen S. Homing of mucosal leukocytes to joints: distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest. 1997;99:2165-72.
52. Grober JS, Bowen BL, Ebling H, Athey B, Thompson CB, Fox DA, Stoolman LM. Monocyte-endothelial adhesion in chronic rheumatoid arthritis: in situ detection of selectin and integrin-dependent interactions. J Clin Invest. 1993;91:2609-19.
53. Rüssmann H, Ruckdeschel K, Heesemann J. Translocation of Yersinia enterocolitica through an endothelial monolayer by polymorphonuclear leukocytes. Infect Immun. 1996;64:1016-9.
54. Granfors K, Toivanen A. IgA-anti-yersinia antibodies in yersinia-triggered reactive arthritis. Ann Rheum Dis. 1986;45:561-65.
55. Mielants H, Veys EM, Cuvelier C, De Vos M. Course of gut inflammation in spondylarthropathies and therapeutic consequences. Baillìere's Clin Rheumatol. 1996;10:147-64.
56. Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppälä K. High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum. 1994;37:23-31.
57. Serrander R, Magnusson K-E, Kihlström E, Sundqvist T. Acute Yersinia infections in man increase intestinal permeability for low-molecular weight polyethylene glycols (PEG 400). Scand J Infect Dis. 1986;18:409-13.
58. Lahesmaa-Rantala R, Magnusson K-E, Granfors K, Leino R, Sundqvist T, Toivanen A. Intestinal permeability in patients with Yersinia-triggered reactive arthritis. Ann Rheum Dis. 1991;50:91-4.
59. Saario R, Leino R, Lahesmaa R, Granfors K, Toivanen A. Function of terminal ileum in patients with Yersinia-triggered reactive arthritis. J Intern Med. 1992;232:73-6.
60. Maki-Ikola O, Lehtinen K, Nissilä M, Granfors K. IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis. Br J Rheumatol. 1994;33:1025-9.
61. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernández-Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359-64.
62. Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking b2-microglobulin: a model of human spondyloarthropathies. J Exp Med. 1995;182:1153-8.
63. Gaston JSH. Pathogenic role of gut inflammation in the spondyloarthropathies. Curr Opin Rheumatol. 1997;9:302-7.
64. Inman RD, Chiu B, Johnston MEA, Vas S, Falk J. HLA class I-related impairment in IL-2 production and lymphocyte response to microbial antigens in reactive arthritis. J Immunol. 1989;142:4256-60.
65. Vuento R, Leino R, Viander M, Toivanen A. In vitro lymphoproliferative response to Yersinia: depressed response in arthritic patients years after Yersinia infection. Clin Exp Rheumatol. 1983;1:219-24.
66. Hermann E, Sucké B, Droste U, Meyer zum Büschenfelde K-H. Klebsiella pneumoniae-reactive T cells in blood and synovial fluid of patients with ankylosing spondylitis: comparison with HLA-B27+ healthy control subjects in a limiting dilution study and determination of the specificity of synovial fluid T cell clones. Arthritis Rheum. 1995;38:1277-82.
67. Ackermann B, Staege MS, Reske-Kunz AB, Dienes HP, Meyer zum Büschenfelde KH, Märker-Hermann E. Enterobacteria-infected T cells as antigen-presenting cells for cytotoxic CD8 T cells: a contribution to the self-limitation of cellular immune reactions in reactive arthritis? J Infect Dis. 1997;175:1121-7.
68. Nossner E, Goldberg JE, Naftzger C, Lyu SC, Clayberger C, Krensky AM. HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family. J Exp Med. 1996;183:339-48.
69. Stagg AJ, Hughes RA, Keat ACS, Elsley WAJ, Knight SC. Antigen-presenting cells but not lymphocytes in the joint may indicate the cause of reactive arthritis. Br J Rheumatol. 1996;35:1082-90.
70. Gaston JS, Deane KH, Jecock RM, Pearce JH. Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. J Rheumatol. 1996;23:130-6.
71. Hermann E, Lohse AW, van der Zee R, van Eden W, Mayet WJ, Probst P, et al. Synovial fluid-derived Yersinia-reactive T cells responding to human 65 kDa heat-shock protein and heat-stressed antigen-presenting cells. Eur J Immunol. 1991;21:2139-43.
72. Hermann E, Yu DTY, Meyer zum Büschenfelde K-H, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993;342:646-50.
73. Probst P, Hermann E, Meyer zum Büschenfelde K-H, Fleischer B. Multiclonal synovial T cell response to Yersinia enterocolitica in reactive arthritis: the Yersinia 61-kDa heat-shock protein is not the major target antigen. J Infect Dis. 1993;167:385-91.
74. Mertz A, Lauster R, Braun J, Sieper J. Occurrence of the TH1-like T cell clones (TCC) specific for nonconserved regions and TH2-like TCC recognizing conserved regions of the HSP60 of Yersinia enterocolitica (Y.E.) in yersinia-arthritis patients. Arthritis Rheum. 1997;40:S260.
75. Mertz AKH, Daser A, Skurnik M, Wiesmüller K-H, Braun J, Appel H, et al. The evolutionarily conserved ribosomal protein L23 and the cationic urease β-subunit of Yersinia enterocolitica O:3 belong to the immunodominant antigens in yersinia-triggered reactive arthritis: implications for autoimmunity. Mol Med. 1994;1:44-55.
76. Probst P, Hermann E, Meyer zum Büschenfelde K-H, Fleischer B. Identification of the Yersinia enterocolitica urease b subunit as a target antigen for human synovial T lymphocytes in reactive arthritis. Infect Immun. 1993;61:4507-49.
77. Lahesmaa R, Soderberg C, Bliska J, Allsup A, Luukkainen R, Steinman L, et al. Pathogen antigen- and super-antigen-reactive synovial fluid T cells in reactive arthritis. J Infect Dis. 1995;172:1290-7.
78. García F, Marina A, Albar JP, Lopez de Castro JA. HLA B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. Tissue Antigens. 1997;49:23-8.
79. Hermann E, Ackermann B, Duchmann R, Meyer zum Büschenfelde K-H. Synovial fluid MHC-unrestricted gd-T lymphocytes contribute to antibacterial and anti-self cytotoxicity in the spondyloarthropathies. Clin Exp Rheumatol. 1995;13:187-91.
80. Märker-Hermann E, Meyer zum Büschenfelde K-H, Wildner G. HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis. Arthritis Rheum. 1997;40:2047-54.
81. Scofield RH, Kurien B, Gross T, Warren WL, Harley JB. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet. 1995;345:1542-4.
82. Davenport MP. The promiscuous B27 hypothesis. Lancet. 1995;346:500-1.
83. Wuorela M, Jalkanen S, Kirveskari J, Laitio P, Granfors K. Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Infect Immun. 1997;65:2060-6.
84. Amor B, Kahan A, Georgiadis AE. Transient loss of HLA B27. Lancet. 1978;1:284.
85. Neumüller J, Fischer M, Eberl R. Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis. Rheumatol Int. 1993; 13:163-7.
86. Kirveskari J, Kellner H, Wuorela M, Soini H, Frankenberger B, Leirisalo-Repo M, et al. False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction. Br J Rheumatol. 1997;36:185-9.
87. Huang F, Yamaguchi A, Tsuchiya N, Ikawa T, Tamura N, Virtala MMK, et al. Induction of alternative splicing of HLA-B27 by bacterial invasion. Arthritis Rheum. 1997;40:694-703.
88. Ringrose JH, Yard BA, Muijsers A, Boog CJP, Feltkamp TEW. Comparison of peptides eluted from the groove of HLA-B27 from Salmonella infected and non-infected cells. Clin Rheumatol. 1996;15:374-8.
89. Boisgérault F, Mounier J, Stolzenberg M-C, Tieng V, Schmitt M, Sansonetti P, et al. Effects of Shigella infection on HLA-B27 biosynthesis, expression and peptide presentation. Arthritis Rheum. 1997;40:S259.
90. Ugrinovic S, Mertz A, Braun J, Sieper J. A single nonamer from the Yersinia 60Kd heat shock protein is the target of HLA-B27 restricted CTL response in Yersmia-induced reactive arthritis. J Immunol. 1997;in press:
91. Gao X-M, Wordsworth P, McMichael AJ, Kyaw MM, Seifert M, Rees D, Dougan G. Homocysteine modification of HLA antigens and its immunological consequences. Eur J Immunol. 1996;26:1443-50.
92. Geczy AF, McGuigan LE, Sullivan JS, Edmonds JP. Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis. J Exp Med. 1986;164:932-7.
93. Kapasi K, Inman RD. HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells. J Immunol. 1992;148:3554-9.
94. Virtala M, Kirveskari J, Granfors K. HLA-B27 modulates the survival of Salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production. Infect Immun. 1997;65:4236-42.
95. Alvarez OO, Finlay BB, Yu DTY, Petty RE. HLA-B27 does not influence invasion of arthritogenic bacteria into human cells. Arthritis Rheum. 1996;39:8162.
96. Laitio P, Virtala M, Salmi M, Pelliniemi LJ, Yu DTY, Granfors K. HLA-B27 modulates intracellular survival of Salmonella enteritidis on human monocytic cells. Eur J Immunol. 1997;27:1331-8.
97. Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frölich JC. Elevated serum nitrate concentrations in active spondyloarthropathies. Br J Rheumatol. 1995;34:616-9.
98. De Groote MA, Testerman T, Xu Y, Stauffer G, Fang FC. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science. 1996;272:414-7.